| Vascular mimicry: a novel neovascularization mechanism driving anti-angiogenic therapy (AAT) resistance in glioblastoma K Angara, TF Borin, AS Arbab Translational oncology 10 (4), 650-660, 2017 | 135 | 2017 |
| miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3 M Boufraqech, L Zhang, M Jain, D Patel, R Ellis, Y Xiong, M He, N Nilubol, ... Endocrine-related cancer 21 (4), 517-531, 2014 | 115 | 2014 |
| MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors D Patel, M Boufraqech, M Jain, L Zhang, M He, K Gesuwan, N Gulati, ... Surgery 154 (6), 1224-1229, 2013 | 100 | 2013 |
| GSTT1, GSTM1 and GSTP1 genetic polymorphisms and interaction with tobacco, alcohol and occupational exposure in esophageal cancer patients from North India M Jain, S Kumar, N Rastogi, P Lal, UC Ghoshal, A Tiwari, MC Pant, ... Cancer letters 242 (1), 60-67, 2006 | 89 | 2006 |
| TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma M Jain, L Zhang, M He, YQ Zhang, M Shen, E Kebebew Endocr Relat Cancer 20 (3), 361-370, 2013 | 82 | 2013 |
| Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma R Upadhyay, M Jain, S Kumar, UC Ghoshal, B Mittal Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 663 (1 …, 2009 | 75 | 2009 |
| KIAA0101 is overexpressed, and promotes growth and invasion in adrenal cancer M Jain, L Zhang, EE Patterson, E Kebebew PloS one 6 (11), e26866, 2011 | 67 | 2011 |
| Association of TNFA (− 308G> A) and IL-10 (− 819C> T) promoter polymorphisms with risk of cervical cancer HO Singh, M Jain, R Sachan, B Mittal International Journal of Gynecologic Cancer 19 (7), 2009 | 64 | 2009 |
| Role of GSTM3 Polymorphism in the Risk of Developing Esophageal Cancer M Jain, S Kumar, P Lal, A Tiwari, UC Ghoshal, B Mittal Cancer Epidemiology Biomarkers & Prevention 16 (1), 178-181, 2007 | 57 | 2007 |
| Vascular mimicry in glioblastoma following anti-angiogenic and anti-20-HETE therapies K Angara, MH Rashid, A Shankar, R Ara, A Iskander, TF Borin, M Jain, ... Histology and histopathology 32 (9), 917, 2017 | 55 | 2017 |
| RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma Y Liu-Chittenden, M Jain, K Gaskins, S Wang, MJ Merino, S Kotian, ... Oncogene 36 (25), 3541-3552, 2017 | 54 | 2017 |
| ZNF367 Inhibits Cancer Progression and Is Targeted by miR-195 M Jain, L Zhang, M Boufraqech, Y Liu-Chittenden, K Bussey, MJ Demeure, ... PloS one 9 (7), e101423, 2014 | 52 | 2014 |
| MMP-7 (− 181A> G) promoter polymorphisms and risk for cervical cancer HO Singh, M Jain, B Mittal Gynecologic oncology 110 (1), 71-75, 2008 | 51 | 2008 |
| Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth BR Achyut, K Angara, M Jain, TF Borin, MH Rashid, ASM Iskander, R Ara, ... Scientific reports 7 (1), 13754, 2017 | 48 | 2017 |
| Integrated analysis of genome-wide methylation and gene expression shows epigenetic regulation of CYP11B2 in aldosteronomas B Howard, Y Wang, P Xekouki, FR Faucz, M Jain, L Zhang, PG Meltzer, ... The Journal of clinical endocrinology and metabolism 99 (3), E536, 2014 | 46 | 2014 |
| Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer M Jain, S Kumar, P Lal, A Tiwari, UC Ghoshal, B Mittal Cancer Detection and Prevention 31 (3), 225-232, 2007 | 46 | 2007 |
| Association of interleukin-6 (− 174G> C) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location: an exploratory study R Upadhyay, M Jain, S Kumar, UC Ghoshal, B Mittal Clinical Immunology 128 (2), 199-204, 2008 | 45 | 2008 |
| Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer M Jain, AR Tilak, R Upadhyay, A Kumar, B Mittal Toxicology and applied pharmacology 230 (2), 247-251, 2008 | 44 | 2008 |
| Influence of apoptosis (BCL2, FAS), cell cycle (CCND1) and growth factor (EGF, EGFR) genetic polymorphisms on survival outcome: an exploratory study in squamous cell esophageal … M Jain, R Upadhyay, S Kumar, P Lal, A Tiwari, UC Ghoshal, B Mittal Cancer biology & therapy 6 (10), 1553-1558, 2007 | 38 | 2007 |
| Interleukin‐13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma M Jain, L Zhang, M He, EE Patterson, N Nilubol, AT Fojo, B Joshi, R Puri, ... Cancer 118 (22), 5698-5708, 2012 | 36 | 2012 |
B R AchyutLabcorp在 labcorp.com 的电子邮件经过验证
